Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma

Androgen Receptor (AR) signaling is a critical driver of hormone-dependent prostate cancer and has also been proposed to have biological activity in female hormone-dependent cancers, including type I endometrial carcinoma (EMC). In this study, we evaluated the preclinical efficacy of a third-generat...

Descripción completa

Detalles Bibliográficos
Autores principales: Koivisto, Christopher S., Parrish, Melodie, Bonala, Santosh B., Ngoi, Soo, Torres, Adrian, Gallagher, James, Sanchez-Hodge, Rebekah, Zeinner, Victor, Nahhas, Georges J., Liu, Bei, Cohn, David E., Backes, Floor J., Goodfellow, Paul J., Chamberlin, Helen M., Leone, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452078/
https://www.ncbi.nlm.nih.gov/pubmed/32818842
http://dx.doi.org/10.1016/j.neo.2020.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452078/
https://www.ncbi.nlm.nih.gov/pubmed/32818842
http://dx.doi.org/10.1016/j.neo.2020.07.003

Ejemplares similares